Study of physico-chemical properties of potential beta-adrenolytics

Study of physico-chemical properties of potential beta-adrenolytics

The aim of this paper is the study of physico-chemical properties of the chosen compounds, derivatives of 2-hydroxy-3-[2-(4-methoxyphenyl) ethylamino]propyl-4-[(alkoxycarbonyl)amino]benzoates and 2-hydroxy-3-[2-(2-methoxyphenyl)ethylamino]propyl-4-[(alkoxycarbonyl) amino]benzoates with potential ult...

Full description

Bibliographic Details
Main Authors:	Stankovičová M., Bezáková Ž., Mokrý P., Salát P., Kočík M., Csöllei J.
Format:	Article
Language:	English
Published:	Sciendo 2014-12-01
Series:	Acta Facultatis Pharmaceuticae Universitatis Comenianae
Subjects:	ultra-short-acting beta-blockers lipophilicity adsorbability critical micelle concentration
Online Access:	https://doi.org/10.2478/afpuc-2014-0014

Similar Items

The role of beta-adrenolytic drugs in treating anxiety disorders
by: Brudkowska Żaneta, et al.
Published: (2018-09-01)

Synthesis of new (arylcarbonyloxy)aminopropanol derivatives and the determination of their physico-chemical properties
by: Tengler Jan, et al.
Published: (2013-11-01)

Safety and Efficacy of Low-Dose Continuous Infusion of Landiolol, an Ultra-Short-Acting β-blocker, in Cardiac Surgery
by: Manabu Sato, MD, et al.
Published: (2011-01-01)

PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer
by: Souheil Reda, et al.
Published: (2020-12-01)

Beta-blockers in Prevention of Development of Varices and Variceal Bleeding in Cirrhosis: Current Management, Controversies, and Future Directions
by: Dhiraj Tripathi
Published: (2017-06-01)

THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01)

NEBIVOLOL: A THIRD GENERATION BETA BLOCKER AS ANTIHYPERTENSION AGENT
by: Ni Putu Wirantari, et al.
Published: (2013-07-01)

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease
by: Burkes RM, et al.
Published: (2020-12-01)

Assessment of the relationship between the molecular properties of calcium channel blockers and plasma protein binding data
by: Odović Jadranka V., et al.
Published: (2017-01-01)

The effect of the molecular properties of calcium channel blockers on their elimination route
by: Trbojević-Stanković Jasna B., et al.
Published: (2015-01-01)

Beta-blocker use and COPD mortality: a systematic review and meta-analysis
by: Etminan Mahyar, et al.
Published: (2012-09-01)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
by: Sean Duffy, et al.
Published: (2017-06-01)

Efficacy of beta-blockers in the treatment of sepsis
by: Peng Jin, et al.
Published: (2021-01-01)

Beta-Blockers and Cancer: Where Are We?
by: Rita Peixoto, et al.
Published: (2020-05-01)

BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Could beta blocker use in elderly hypertensive patients reduce risk of skin cancers?
by: Erdinc Terzi, et al.
Published: (2019-12-01)

ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW?
by: S. Y. Martsevich
Published: (2016-01-01)

USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?
by: V. V. Samoylenko, et al.
Published: (2015-09-01)

Modifications des propriétés physico-chimiques de la caséine micellaire en présence du peptide f1-8 généré par hydrolyse trypsique de la bêta-lactoglobuline
by: Silveira Porto Oliveira, Raquel, et al.
Published: (2018)

EVALUATION OF BETA-ADRENOBLOCKERS TREATMENT IN CARDIOVASCULAR DISEASES COMORBID WITH DIABETES IN OUTPATIENT SETTING
by: N. A. Komkova, et al.
Published: (2017-12-01)

EXERCISE RESPONSE TO ACUTE AND CHRONIC BETA BLOCKADE IN HEALTHY MALE SUBJECTS
by: Jilka, Sarah Marie, 1960-
Published: (1987)

Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
by: Allen Larry A, et al.
Published: (2012-06-01)

Different pH-sensitivity patterns of 30 sodium channel inhibitors suggest chemically different pools along the access pathway.
by: Alexandra eLazar, et al.
Published: (2015-09-01)

THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Neuropsychiatric Consequences of Lipophilic Beta-Blockers
by: Sabina Alexandra Cojocariu, et al.
Published: (2021-02-01)

Beta adrenergic blockade in myocardial infarction
by: Yusuf, Salim
Published: (1980)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
by: Roberto F.E. Pedretti
Published: (2018-06-01)

Curing Behavior of Waterborne Paint Containing Catalyst Encapsulated in Micelle
by: Shuji Yomo
Published: (2021-03-01)

Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial
by: Raouf Ramzy Gadallah, et al.
Published: (2020-11-01)

Beta-blocker under-use in COPD patients
by: Lim KP, et al.
Published: (2017-10-01)

Beta-blockade is not associated with improved outcomes in isolated severe extracranial injury: an observational cohort study
by: Lin Sadi, et al.
Published: (2021-09-01)

BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST
by: L. N. Malaj
Published: (2016-01-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
by: I V Fomin, et al.
Published: (2017-12-01)

Beta-blockers, and real clinical practice in Russia: the gap between the understanding of the doses of beta-blockers and subsequent prognosis in patients with cardiovascular disease
by: Fomin I.V., et al.
Published: (2017-09-01)

Studying the suitability of hybrid micelle liquid chromatography for estimating the lipophilicity of some partial dopamine agonists used to attain the reward circuit
by: M. E. K. Wahba, et al.
Published: (2021-05-01)

The α 1-adrenolytic and structural evaluation of new pyridoindole derivatives
by: Májeková Magdaléna, et al.
Published: (2006-12-01)